{"cmr":"ch-cm-kg/SIX/NOVN","since":null,"total":34,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-27","event_type":"newswire_release","title":"Novartis delivered sales growth and core margin expansion","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/27/3388691/0/en/novartis-delivered-sales-growth-and-core-margin-expansion-in-q3-raised-fy-core-operating-income-guidance.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sQm_YF2FcCitcNsWXFpx3_l8WYjxrn0Q3F6m5RGWaFfR5yQmSzu5keR5Muk1svgHgq7gdQhra3-5oR5Ax88sCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-23","event_type":"newswire_release","title":"Novartis remibrutinib delivered comprehensive disease","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/23/3387514/0/en/novartis-remibrutinib-delivered-comprehensive-disease-control-in-phase-iii-rms-trials-with-proven-robust-safety-profile.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SquQDwrld7R0JK7cG0EWgi4WiL3_WlpY8NggivpaaZotDCnKXZ1wi8fvAPycgQVaP9QDRZnRKhM827meSsdwAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-23","event_type":"register_mutation","title":"HR02 Change Kaderkasse Novartis, Basel, new Pensionskasse Novartis 3","reference":"HR02-1006791265","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/17e775ce-fa2a-45bb-9fc3-770d03f6429c","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006791265; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Xus2yL7HDxm2BtWaQ0qnNDYCkmlGe_kjtar2nltWX5JAKJzbdKnNl_Lb88V3nWhS1q8oCJTt5lsZqZWi7i-tAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-22","event_type":"register_mutation","title":"HR02 Change Novartis Pharma Schweiz AG, Risch","reference":"HR02-1006789916","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/89dbebe8-5d02-4b66-93a9-bb239ace613c","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006789916; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EViAXlJvg_rkYVz7xxLc3Pi3r-ZNTgQYp7eN07D5EVN4g4z5mcanj9_IlPpr1A0iAszlO7DsoHPoWmWJLFSRBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-21","event_type":"newswire_release","title":"Novartis receives European Commission approval for","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/21/3385726/0/en/novartis-receives-european-commission-approval-for-cosentyx-in-polymyalgia-rheumatica-pmr.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Y2Ll3GSQyd7zEBqaa-jujo4ZkgYlH_6k75osthVJbilR8W0Dt2KwKCiUL0i3pN-vFf5tqsZneFtyRr0ttcNlCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-09","event_type":"register_mutation","title":"HR02 Change Novartis Stiftung für Kaderausbildung, Basel","reference":"HR02-1006779101","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/6ef65402-490b-4dc5-acd6-d21f953c2015","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006779101; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XvVdLJw-biK9-I5xqamNfBi5q9bQtqHBcVo3rtOS7yex1obN-OUoi1t-wFKmC_Xcx2XqfmIPyQ14TyIAYcPtCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-09","event_type":"register_mutation","title":"HR02 Change Novartis Sanierungsstiftung, Basel","reference":"HR02-1006779100","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/ee64fb4a-12f2-47b3-bcc1-192fc2929ecb","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006779100; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fz5e3L-V_yGJS3Ogj1WlrZhp6WfilYg7f0amWW0gmXoMkNK0IeE7WpOWsJM7RcBdkilp19pVFqL2VZpSQVQEDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-08","event_type":"newswire_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-novartis-ag---nvs-302902146.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"IUGE4ybSbj7N7BobxXhfeWzX9V-HHvUYzd5VzCGlKo6YfXKy6UClppLoHHfDQdQozRW36NgemLvg-lUotTjzBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-07","event_type":"newswire_release","title":"Novartis advances multiple sclerosis innovation with","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/07/3376328/0/en/novartis-advances-multiple-sclerosis-innovation-with-late-breaking-remibrutinib-and-broad-portfolio-data-at-mstoronto2026.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6JaF041x8bbgcEA_DESkAkmCMQlVdbgtiwk9lYHcyE4Upg_TjS9U_IxwrYaxDRWgQhy0Iw8zl-Mi-KD2bXZ_Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-07","event_type":"newswire_release","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"jnya4dKIuyYFvrU2SBHeypFd0h60H0MP5t2N7DsSu3OG6-qQOZvVKkDFngPH9O7NZX3Cc4CJg4Ktm36FMjbvDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-07","event_type":"register_mutation","title":"HR02 Change Novartis Bioventures AG, Basel","reference":"HR02-1006776582","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/7e439325-ce11-4892-84c7-2d53462a4684","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006776582; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XfPZuIIJpdvSIx2fyYVp4_wQ25NIky9Gf0j_htY-jOJbIGX9seUS6Adak_gug1NyPoF_LrBQW02a4dneKtrnAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-07","event_type":"register_mutation","title":"HR02 Change Novartis International AG, Basel","reference":"HR02-1006776583","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/b0dfbaa0-914d-4321-b778-b03eb95bffbf","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006776583; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9WGjHQbNhHCqecDep9pHsj3P_1KrGCjYNvt8Wtgwl33DtWKDSLvVxU1xkXyCI_Qwpy_v7GpDKWRTCmZZbbOKCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-02","event_type":"register_mutation","title":"HR02 Change Novartis AG, Basel","reference":"HR02-1006772370","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/30b4534a-f042-478d-8949-4e5f2a51a3da","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006772370; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"3i52BHJSIvfvmr5UbZIxuML4ZeksRYRn-qZ3YTP5mFlDJUc8jxW5XLuhqHdVJH9H00W5XtWXtBc5w6OGEVZ0BQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-02","event_type":"register_mutation","title":"HR02 Change Novartis International AG, Basel","reference":"HR02-1006772371","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/88f4ddf2-6625-4563-bc66-3a21e4cd79aa","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006772371; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xNO7CR5rG50lkaLswvD2qaZH9Uz_qhejBSsvI5Stxd7j4aLwwz6vtlLoTU6tb8cSWXCLsRrO4bdh2IxK8HK7DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-10-01","event_type":"newswire_release","title":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-novartis-ag---nvs-302895440.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SM7qEqfMg21XRmLbPw5wsonZKE4m8mfEA0WlaoHIWTi6jpoPkHhU5DfjS_5hRRXT1iACWxvTiuehWYk4zkB7BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-09-25","event_type":"register_mutation","title":"HR02 Change Novartis Lateinamerika AG, Basel","reference":"HR02-1006766061","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/1b1300fb-08ae-409a-801e-10ce88df1daa","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006766061; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_VydDwY54TwffQjdM6j9nfk_O76v98bHdkxvRR6DtyVvSvvBUBvDZCtjAbTndk-esM7NGP90ZLN05cKnjKy8BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-09-25","event_type":"register_mutation","title":"HR02 Change Novartis International Pharmaceutical Investment AG, Basel","reference":"HR02-1006766060","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/2ed6f42e-4c88-4516-a1ea-8ef6fd88904f","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006766060; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dXXidOzEnBAI2CbiTDDsIVVLGfu6Z9BEJooUoE-RhDPwUML7EvJ8tmtft9hQaLkKcqQCMeLuJ8oZixNH0N5nAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-09-11","event_type":"newswire_release","title":"Bronstein, Gewirtz & Grossman, LLC Is Investigating Novartis AG ...","wire":"ACCESS Newswire","source":"ACCESS Newswire","url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-is-investigating-novartis-ag-1219571","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"FFaDdA3JmVhNBDfXU3xNa--wORsXMGuKJYZYyIJ3bKXu39V0p-_HjhZphtNvGyrZ_q3ejnILzbNC3WwLA9dsDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-09-09","event_type":"newswire_release","title":"Novartis Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Novartis (NVS)","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/novartis-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-novartis-nvs-302874095.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"QOrg5jweDXeSAlnka1X_jZoegpAqZHmupuOt9pJOxtzN3G9Ufb6WqDCIjYRdlGsyQpq0HcK_uu55GyCjF3QMDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-09-08","event_type":"newswire_release","title":"Novartis provides update on delpacibart etedesiran","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/08/3357301/0/en/novartis-provides-update-on-delpacibart-etedesiran-del-desiran-phase-iii-harbor-study-for-the-treatment-of-myotonic-dystrophy-type-1-dm1.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hd8ad2aLHylZ6TW-u4zdT5bvmRjfnvEKLYBEx54EETQ6zlI6OfIljdVuJ0NKPpbCYtwa7kluas41d9Uw_1EpDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-07-16","event_type":"newswire_release","title":"Novartis Fabhalta® (iptacopan) receives FDA traditional","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/07/16/3328875/0/en/novartis-fabhalta-iptacopan-receives-fda-traditional-approval-as-first-and-only-complement-inhibitor-to-significantly-slow-kidney-function-decline-in-primary-igan.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TGksZpHKoEmilaO9zXjtwuAwjpyz-P1nESNgAO4qmmp8p35vHsOWingoQk40Ss92qjlU9C4RDJP6tHGDdSLVCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-07-13","event_type":"register_mutation","title":"HR02 Change Novartis AG, Basel","reference":"HR02-1006705107","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/d3a0958a-fc38-4c1e-bd6e-81c327ed0f6a","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006705107; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"n8iOmJAR9R_63bgr27MMLZhDKAbINUkGz3hchRkeVZD4ZEzsD3BSLXI3uOntqeduuwdPjbakg0NWegjWAkVtCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-07-06","event_type":"newswire_release","title":"Brandon Capital Announces Agreement for Novartis to Acquire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/07/06/3322140/0/en/brandon-capital-announces-agreement-for-novartis-to-acquire-portfolio-company-myricx-bio-to-advance-new-class-of-cancer-therapeutics.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"G6_VapKv3JmnOfi-UZBRrcBD7GlfEklrzgvZX4xrSLd29zgibO8CmT0CW8f5VwHOyTU3jH1mUtk06Zmy_KLDAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-06-10","event_type":"register_mutation","title":"HR02 Change Novartis AG, Basel","reference":"HR02-1006672639","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/41d9609c-c14d-4ea3-85dc-ba2a93098f15","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006672639; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"WLwxxRMEvlH_nR8XoMyBrwkEwF3mT7WjKlcN6Gmbl2GnUsgVIGXDuVtqXfTR84e3_W4GG8ADYeYitaLiuBavDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-05-01","event_type":"register_mutation","title":"HR02 Change Novartis AG, Basel","reference":"HR02-1006640430","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/f356beb8-fdfc-4f1f-9259-8bc954bf822d","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006640430; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iwtqSO8WN5me2ssCqKO1_v0LkkSousdITqPw9SZE-5QitVOZfVlOh_80N3DWnhfG2Kx3acqgCvf9AEa8Rd4IAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-04-09","event_type":"newswire_release","title":"Novartis announces expansion of community health programs","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/09/3270644/0/en/novartis-announces-expansion-of-community-health-programs-to-close-gaps-in-heart-disease-and-cancer-care-targeting-more-than-30-countries-by-2030.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"X0SLE8p6pyDirQY2EU0yT4fNsy1BsCUUb_7mABgvfTtNJ37Te9WCb2QSHL8z4ZhxU19Tt3V8gfXUALrbJfKOAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-04-09","event_type":"newswire_release","title":"Novartis announces expansion of community health programs","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/09/3270643/0/en/Novartis-announces-expansion-of-community-health-programs-to-close-gaps-in-heart-disease-and-cancer-care-targeting-more-than-30-countries-by-2030.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"QAwhrAn4frOptgYQRS796ZdTFggR9Hr2EDxfVYaeii7oUY9W7D8SwYQFN8cmJxSk0x1XjmajUjifH-mcQ56HBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-03-23","event_type":"register_mutation","title":"HR02 Change Novartis AG, Basel","reference":"HR02-1006603686","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/96cc7f8c-67e2-4561-81a0-7649d3b8979e","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006603686; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1gFqMpXLOklO13N4aIQ3Q0xXuDhmF4uCgcGz_jOqf_haVhvmc5HkApWznR0fE-Z7_-IT6ZzhRTKvDa09BgBXBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-02-24","event_type":"register_mutation","title":"HR02 Change Novartis AG, Basel","reference":"HR02-1006578202","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/74c58be7-8ad1-417a-a022-165c206e2eef","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006578202; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5VenYqFcEyp4NZrEGJ8Gf1VgsjPcnRKFYNpmkRcHR4eKgtrTNPQqwa92Utd1JoGvD3UWfWi-ljKMc_B9RZhGCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2026-01-29","event_type":"newswire_release","title":"NFL Greats and Novartis Tackle Prostate Cancer Myths at Super ...","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/nfl-greats-and-novartis-tackle-prostate-cancer-myths-at-super-bowl-lx-relax-its-a-blood-test-302673375.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RH1u_258X8H7_FzmBaBlQ66CLjfn_Jb_iOItFpQD-W0kXbBV8LtYpg7jsArJuBq2DVZEMB4I1-pZax6JtDdXBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2025-12-09","event_type":"newswire_release","title":"Relation announces strategic collaboration with Novartis to","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/09/3202076/0/en/Relation-announces-strategic-collaboration-with-Novartis-to-advance-therapeutics-for-atopic-diseases.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ChZPRe27KIsfnegRv60Pe0JMLKMjVdfo-pyFSC8FJxpgz0zW2HowgN7UJbzZbs0_QpsjvhCD7I9yOGFcTioSCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2025-11-19","event_type":"newswire_release","title":"Novartis announces plans to build flagship manufacturing","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/19/3191303/0/en/Novartis-announces-plans-to-build-flagship-manufacturing-hub-in-North-Carolina.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Lq_RRfS2uxLKSrWk1T4rXzdm5i3Y7bnGqWYvVQOzqmA3XeQYKtXJ2xWCv4zsPBgwPB6eVDkBU2nY7lLDz48bBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2025-11-19","event_type":"newswire_release","title":"Novartis announces plans to build flagship manufacturing","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/19/3191304/0/en/Novartis-announces-plans-to-build-flagship-manufacturing-hub-in-North-Carolina.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6F2WI9rkydDoJ5BVX5f8Q2XeTYt_R_HkY0B8phakKKijmdcycP1AeN0DoD66V2DHbBtDAD9wSnSjOJMfqnthCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/SIX/NOVN","date":"2025-11-17","event_type":"register_mutation","title":"HR02 Change Novartis AG, Basel","reference":"HR02-1006486290","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/2dd5b9f8-3f67-4b3c-94aa-b96cb0a4e0df","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006486290; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"jIMJT8o7rJgy2JdPt0QcFWUcYe_WSP1iNfoZse51i-LbdqSpm13pNueTBR5ktoIWJa3o3ZZKkI4-OoY41AugCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}